These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16193347)

  • 21. [Changes of the bone mineral density of proximal femur after hip resurfacing arthroplasty].
    Lian YY; Yoo MC; Pei FX; Cheng JQ; Feng W; Cho YJ; Kim GI; Chun SW
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1091-4. PubMed ID: 18005605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
    Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
    Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
    J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone remodeling around the Cambridge cup: a DEXA study of 50 hips over 2 years.
    Field RE; Cronin MD; Singh PJ; Burtenshaw C; Rushton N
    Acta Orthop; 2006 Oct; 77(5):726-32. PubMed ID: 17068702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty.
    Arabmotlagh M; Pilz M; Warzecha J; Rauschmann M
    J Orthop Res; 2009 Feb; 27(2):183-8. PubMed ID: 18752281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
    Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
    Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periprosthetic BMD after cemented and uncemented total hip arthroplasty: a 10-year follow-up study.
    Tapaninen T; Kröger H; Venesmaa P
    J Orthop Sci; 2015 Jul; 20(4):657-62. PubMed ID: 25850905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dose-dependent prevention of early periprosthetic bone loss by alendronate].
    Hennigs T; Arabmotlagh M; Schwarz A; Zichner L
    Z Orthop Ihre Grenzgeb; 2002; 140(1):42-7. PubMed ID: 11898063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial.
    Muren O; Akbarian E; Salemyr M; Bodén H; Eisler T; Stark A; Sköldenberg O
    Acta Orthop; 2015; 86(5):569-74. PubMed ID: 25885280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial.
    Wilkinson JM; Eagleton AC; Stockley I; Peel NF; Hamer AJ; Eastell R
    J Orthop Res; 2005 Jan; 23(1):1-8. PubMed ID: 15607868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density and single photon emission computed tomography changes after total knee arthroplasty: a 2-year follow-up study.
    Soininvaara T; Nikola T; Vanninen E; Miettinen H; Kröger H
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):101-6. PubMed ID: 18076657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in bone mineral density in the proximal femur after cementless total hip arthroplasty. A five-year longitudinal study.
    Brodner W; Bitzan P; Lomoschitz F; Krepler P; Jankovsky R; Lehr S; Kainberger F; Gottsauner-Wolf F
    J Bone Joint Surg Br; 2004 Jan; 86(1):20-6. PubMed ID: 14765859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty.
    Yamaguchi K; Masuhara K; Yamasaki S; Nakai T; Fuji T
    Bone; 2003 Jul; 33(1):144-9. PubMed ID: 12919709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tartrate-resistant acid phosphatase 5b (TRAP 5b) as a marker of osteoclast activity in the early phase after cementless total hip replacement.
    Habermann B; Eberhardt C; Feld M; Zichner L; Kurth AA
    Acta Orthop; 2007 Apr; 78(2):221-5. PubMed ID: 17464610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of alendronate on bone mineral density in men with prostate cancer treated with androgen deprivation therapy.
    Bruder JM; Ma JZ; Wing N; Basler J; Katselnik D
    J Clin Densitom; 2006; 9(4):431-7. PubMed ID: 17097529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone loss after total hip arthroplasty.
    Dan D; Germann D; Burki H; Hausner P; Kappeler U; Meyer RP; Klaghofer R; Stoll T
    Rheumatol Int; 2006 Jul; 26(9):792-8. PubMed ID: 16763871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone Remodelling in the Proximal Femur after Uncemented Total Hip Arthroplasty in Patients with Osteoporosis].
    Lacko M; Schreierová D; Čellár R; Vaško G
    Acta Chir Orthop Traumatol Cech; 2015; 82(6):430-6. PubMed ID: 26787184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia.
    Gilfillan CP; Strauss BJ; Rodda CP; Bowden DK; Kean AM; Obaid M; Crawford BA
    Calcif Tissue Int; 2006 Sep; 79(3):138-44. PubMed ID: 16969592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem anteversion affects periprosthetic bone mineral density after total hip arthroplasty.
    Hayashi S; Hashimoto S; Kanzaki N; Kuroda R; Kurosaka M
    Hip Int; 2016 May; 26(3):260-4. PubMed ID: 27102558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.